| RS1554852789 |
SUFU
|
Health Risk |
Likely pathogenic |
— |
| RS1554852945 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554853026 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS1554853606 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554853667 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, VPS13B-related disorder |
| RS1554853676 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554853682 |
SLC52A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS1554853875 |
SLC52A2
|
Health Risk |
Likely pathogenic |
— |
| RS1554854044 |
SLC52A2
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS1554854341 |
SLC52A2
|
Health Risk |
Likely pathogenic |
Sensorineural hearing loss disorder, Brown-Vialetto-van Laere syndrome 2 |
| RS1554854612 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS1554856032 |
PAX2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 7, Renal coloboma syndrome |
| RS1554856034 |
PAX2
|
Health Risk |
Pathogenic |
— |
| RS1554856042 |
CDH23
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 12 |
| RS1554857529 |
CDHR1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1554857840 |
CDH23
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS1554857855 |
FANCC
|
Health Risk |
Likely pathogenic |
— |
| RS1554858130 |
KIF11
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1554858249 |
FANCC
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia |
| RS1554858698 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1554859292 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS1554859309 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1554859344 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS1554859399 |
KIF11
|
Health Risk |
Likely pathogenic |
— |
| RS1554859966 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1554860819 |
KIF11
|
Health Risk |
Likely pathogenic |
— |
| RS1554861288 |
CFAP43
|
Health Risk |
Pathogenic |
Spermatogenic failure 19, Spermatogenic failure 19 |
| RS1554861545 |
KIF11
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1554862197 |
KIF11
|
Health Risk |
Likely pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1554862218 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1554862262 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554862423 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS1554862427 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1554862601 |
CPSF1
|
Health Risk |
Pathogenic |
Myopia 27, Myopia 27 |
| RS1554862953 |
CFAP43
|
Health Risk |
Pathogenic |
Spermatogenic failure 19, Spermatogenic failure 19 |
| RS1554863016 |
KIF11
|
Health Risk |
Likely pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1554863044 |
KIF11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554863182 |
KIF11
|
Health Risk |
Likely pathogenic |
— |
| RS1554863201 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1554863246 |
KIF11
|
Health Risk |
Likely pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1554864404 |
LIPA
|
Health Risk |
Likely pathogenic |
Cholesteryl ester storage disease, Cholesteryl ester storage disease |
| RS1554864768 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Myofibrillar myopathy 4 |
| RS1554865146 |
PAX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554865199 |
LIPA
|
Health Risk |
Likely pathogenic |
Cholesteryl ester storage disease, Cholesteryl ester storage disease |
| RS1554865206 |
LIPA
|
Health Risk |
Pathogenic |
Wolman disease, Cholesteryl ester storage disease |
| RS1554865214 |
LIPA
|
Health Risk |
Likely pathogenic |
Wolman disease, Cholesteryl ester storage disease |
| RS1554865576 |
LIPA
|
Health Risk |
Pathogenic |
Wolman disease, Wolman disease |
| RS1554865817 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
LIPA-related disorder, LIPA-related disorder |
| RS1554866004 |
LIPA
|
Health Risk |
Pathogenic |
Cholesteryl ester storage disease, Wolman disease |
| RS1554866097 |
LIPA
|
Health Risk |
Likely pathogenic |
Lysosomal acid lipase deficiency, Wolman disease |
| RS1554867189 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1554867698 |
OAT
|
Health Risk |
Likely pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS1554867753 |
PRF1
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Familial hemophagocytic lymphohistiocytosis 2 |
| RS1554867854 |
OAT
|
Health Risk |
Pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS1554869292 |
LIPA
|
Health Risk |
Likely pathogenic |
Cholesteryl ester storage disease, Cholesteryl ester storage disease |
| RS1554869370 |
PAPSS2
|
Health Risk |
Likely pathogenic |
— |
| RS1554871138 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1554871182 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS1554871810 |
SLC39A4
|
Health Risk |
Likely pathogenic |
Hereditary acrodermatitis enteropathica, Hereditary acrodermatitis enteropathica |
| RS1554871816 |
CDH23
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 12 |
| RS1554872194 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS1554872740 |
SLC39A4
|
Health Risk |
Likely pathogenic |
Hereditary acrodermatitis enteropathica, Hereditary acrodermatitis enteropathica |
| RS1554873550 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1F, Autosomal recessive nonsyndromic hearing loss 23 |
| RS1554873649 |
SLC39A4
|
Health Risk |
Likely pathogenic |
Hereditary acrodermatitis enteropathica, Hereditary acrodermatitis enteropathica |
| RS1554873833 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS1554873950 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2 |
| RS1554873973 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME |
| RS1554874073 |
ERCC6
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2 |
| RS1554874130 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1554874148 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1554874373 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 12 |
| RS1554874859 |
ATAD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperekplexia 4, Hyperekplexia 4 |
| RS1554874879 |
CDH23
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 12 |
| RS1554874884 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS1554874900 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS1554875114 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME |
| RS1554875154 |
ERCC6
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME |
| RS1554875155 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome type 2 |
| RS1554875287 |
ERCC6
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME |
| RS1554875409 |
BAG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS1554875522 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME |
| RS1554875536 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome |
| RS1554876984 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1554876990 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS1554876999 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS1554877001 |
BAG3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1HH |
| RS1554877007 |
CDH23
|
Health Risk |
Pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS1554877037 |
BAG3
|
Health Risk |
Likely pathogenic |
— |
| RS1554877224 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1554877731 |
BAG3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1554877765 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS1554877797 |
CDH23
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 12 |
| RS1554877806 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Pituitary adenoma 5 |
| RS1554878076 |
TONSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554879059 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1554879411 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1554879633 |
EHMT1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554879741 |
PSAP
|
Health Risk |
Likely pathogenic |
Combined PSAP deficiency, Krabbe disease due to saposin A deficiency |
| RS1554879785 |
PSAP
|
Health Risk |
Likely pathogenic |
— |
| RS1554879846 |
CYP17A1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 17-alpha-monooxygenase, Deficiency of steroid 17-alpha-monooxygenase |